Literature DB >> 9820820

Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

O M El-Agnaf1, G B Irvine, G Fitzpatrick, W K Glass, D J Guthrie.   

Abstract

In an attempt to answer the question of whether or not the so-called tachykinin-like region of the Alzheimer beta-amyloid protein [Abeta(25-35)] can act as a tachykinin, the sequences Abeta(25-35), Abeta(25-35)amide and their norleucine-35 and phenylalanine-31 analogues were synthesized. These peptides were examined with ligand binding studies, electron microscopy, CD and NMR. In all cases some differences were found between the Abeta(25-35) analogue and the corresponding Phe31 peptide. In addition, in ligand displacement studies on tachykinin NK1 receptors, only the Phe31 analogue showed activity comparable to that of genuine tachykinins. We conclude that peptides based on Abeta(25-35) but with a Phe residue at position 31 do display properties typical of a tachykinin, but that peptides with Ile at this position do not.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820820      PMCID: PMC1219887          DOI: 10.1042/bj3360419

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Receptor-mediated specific biological activity of a beta-amyloid protein fragment for NK-1 substance P receptors.

Authors:  Y Shimohigashi; H Matsumoto; Y Takano; R Saito; T Iwata; H Kamiya; M Ohno
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

2.  Solution structure of residues 1-28 of the amyloid beta-peptide.

Authors:  J Talafous; K J Marcinowski; G Klopman; M G Zagorski
Journal:  Biochemistry       Date:  1994-06-28       Impact factor: 3.162

Review 3.  Normal and abnormal biology of the beta-amyloid precursor protein.

Authors:  D J Selkoe
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

4.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

Authors:  C J Barrow; A Yasuda; P T Kenny; M G Zagorski
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

5.  Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate.

Authors:  H Kimura; D Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.

Authors:  K Sorimachi; D J Craik
Journal:  Eur J Biochem       Date:  1994-01-15

7.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.

Authors:  C J Pike; D Burdick; A J Walencewicz; C G Glabe; C W Cotman
Journal:  J Neurosci       Date:  1993-04       Impact factor: 6.167

8.  Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.

Authors:  H Fabian; G I Szendrei; H H Mantsch; L Otvos
Journal:  Biochem Biophys Res Commun       Date:  1993-02-26       Impact factor: 3.575

9.  Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.

Authors:  L K Simmons; P C May; K J Tomaselli; R E Rydel; K S Fuson; E F Brigham; S Wright; I Lieberburg; G W Becker; D N Brems
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

10.  Amyloid beta protein does not interact with tachykinin receptors coupled to inositol phospholipid hydrolysis in human astrocytoma cells.

Authors:  M Di Stefano; G Aleppo; G Casabona; A A Genazzani; U Scapagnini; F Nicoletti
Journal:  Brain Res       Date:  1993-01-08       Impact factor: 3.252

View more
  4 in total

1.  Solution structure of the tachykinin peptide eledoisin.

Authors:  R Christy Rani Grace; Indu R Chandrashekar; Sudha M Cowsik
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

2.  Structure of A beta(25-35) peptide in different environments.

Authors:  Ganesh Shanmugam; Prasad L Polavarapu
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

3.  Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents.

Authors:  Silvia Dante; Thomas Hauss; Norbert A Dencher
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

4.  Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.

Authors:  Guanghong Wei; Joan-Emma Shea
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.